BioLargo, Inc. Engagement Extension AgreementEngagement Extension Agreement • October 2nd, 2015 • Biolargo, Inc. • Chemicals & allied products
This Engagement Extension Agreement (the “Extension”) references the Engagement Agreement and Scope Letter dated February 1, 2008 (“2008 Agreement”) by and between CFO 911 Corporation (the “Advisor)” and BioLargo, Inc. (the “Company”), and written extensions to the Agreement (the “Prior Extensions”), pursuant to which Charles K. Dargan II has been serving as the Company’s Chief Financial Officer. The parties desire to extend the terms of the prior agreements for a period of one year, pursuant to the terms of this Extension. The 2008 Agreement, the Prior Extensions and this Extension are collectively referred to herein as the “Agreement”.
NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • October 2nd, 2015 • Biolargo, Inc. • Chemicals & allied products • Delaware
This Non-qualified Stock Option Agreement (this “Agreement”) is made and entered into as of September 30, 2015 (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), whose address is 3500 West Garry Avenue, Santa Ana, California 92704, and Charles K. Dargan II, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in the BioLargo, Inc. 2007 Equity Incentive Plan (the “Plan”, a copy of which is attached hereto as Appendix A and incorporated by this reference).
